Att 2_published 60d FRN

Federal Register / Vol. 81, No. 54 / Monday, March 21, 2016 / Notices
of literature, research, and studies on
the health effects of toxic substances’’
under CERCLA Section 104(i)(1)(B), to
respond to requests for consultation
under section 104(i)(4), and to support
the site-specific response actions
conducted by ATSDR, as otherwise
necessary.
Nominations from the Substance
Priority List and/or additional
substances must be submitted within 30
days of the publication of this notice.

DATES:

You may submit
nominations, identified by Docket No.
ATSDR–2016–0004, by any of the
following methods:
*Internet: Access the Federal
eRulemaking portal at http://
www.regulations.gov. Follow the
instructions for submitting comments.
*Mail: Division of Toxicology and
Human Health Sciences, 1600 Clifton
Rd. NE., MS F–57, Atlanta, GA 30333
Instructions: All submissions must
include the agency name and docket
number for this notice. All relevant
comments will be posted without
change. This means that no confidential
business information or other
confidential information should be
submitted in response to this notice.
Refer to the section Submission of
Nominations (below) for the specific
information required.

ADDRESSES:

For
further information, please contact
Commander Jessilynn B. Taylor,
Division of Toxicology and Human
Health Sciences, 1600 Clifton Rd. NE.,
MS F–57, Atlanta, GA 30333, Email:
[email protected]; phone: 770.488.3313.

FOR FURTHER INFORMATION CONTACT:

The
Superfund Amendments and
Reauthorization Act of 1986 (SARA) [42
U.S.C. 9601 et seq.] amended the
Comprehensive Environmental
Response, Compensation, and Liability
Act of 1980 (CERCLA or Superfund) [42
U.S.C. 9601 et seq.] by establishing
certain requirements for ATSDR and the
U.S. Environmental Protection Agency
(EPA) with regard to hazardous
substances most commonly found at
facilities on the CERCLA National
Priorities List (NPL). Among these
statutory requirements is a mandate for
the Administrator of ATSDR to prepare
toxicological profiles for each substance
included on the Priority List of
Hazardous Substances. This list
identifies 275 hazardous substances that
ATSDR and EPA have determined pose
the most significant current potential
threat to human health.

mstockstill on DSK4VPTVN1PROD with NOTICES

SUPPLEMENTARY INFORMATION:

VerDate Sep<11>2014

17:46 Mar 18, 2016

Jkt 238001

15111

Substances To Be Evaluated for Set 30
Toxicological Profiles

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Each year, ATSDR develops a list of
substances to be considered for
toxicological profile development. The
Set 30 nomination process includes
consideration of all substances on
ATSDR’s Priority List of Hazardous
Substances, also known as the
Substance Priority List (SPL), as well as
other substances nominated by the
public. The 275 substances on the SPL,
as well as other substances nominated
by the public, will be considered for Set
30 Toxicological Profile development.
This list may be found at the following
Web site: www.atsdr.cdc.gov/SPL.
Submission of Nominations for the
Evaluation of Set 30 Proposed
Substances: Today’s notice invites
voluntary public nominations for
substances included on the SPL and for
substances not listed on the SPL. All
nominations should include the full
name of the nominator, affiliation, and
email address. When nominating a nonSPL substance, please include the
rationale for the nomination. Please note
that email addresses will not be posted
on regulations.gov.
ATSDR will evaluate all data and
information associated with nominated
substances and will determine the final
list of substances to be chosen for
toxicological profile development.
Substances will be chosen according to
ATSDR’s specific guidelines for
selection. These guidelines can be found
in the Selection Criteria announced in
the Federal Register on May 7, 1993
(58FR27286–27287). A hard copy of the
Selection Criteria is available upon
request or may be accessed at: http://
www.atsdr.cdc.gov/toxprofiles/
guidance/criteria_for_selecting_tp_
support.pdf.
Please ensure that your comments are
submitted within the specified
nomination period. Nominations
received after the closing date will be
marked as late and may be considered
only if time and resources permit.

Centers for Disease Control and
Prevention

Dated: March 15, 2016.
Pamela Protzel Berman,
Acting Associate Director, Office of Policy,
Planning and Evaluation, National Center for
Environmental Health/Agency for Toxic
Substances and Disease Registry.
[FR Doc. 2016–06277 Filed 3–18–16; 8:45 am]
BILLING CODE 4163–70–P

PO 00000

[60Day–16–16TZ; Docket No. CDC–2016–
0028]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project entitled ‘‘Formative
Research to Develop HIV Social
Marketing Campaigns for Healthcare
Providers.’’ CDC seeks a three-year
approval to collect data from health care
providers in order to develop timely,
relevant, clear, and engaging materials
that will support patient-provider
communications related to HIV
prevention.
DATES: Written comments must be
received on or before May 20, 2016.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2016–
0028 by any of the following methods:
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
SUMMARY:

Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.

To
request more information on the
proposed project or to obtain a copy of

FOR FURTHER INFORMATION CONTACT:

Frm 00078

Fmt 4703

Sfmt 4703

E:\FR\FM\21MRN1.SGM

21MRN1

15112

Federal Register / Vol. 81, No. 54 / Monday, March 21, 2016 / Notices

the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and

maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Formative Research to Develop HIV
Social Marketing Campaigns for
Healthcare Providers—New—National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
According to recent estimates,
approximately 1.2 million people are
living with human immunodeficiency
virus (HIV) in the United States, and for
the past several years, approximately
50,000 people have been diagnosed
annually. It is well-established that
certain populations are
disproportionately affected by HIV,
including men who have sex with men
(MSM), African Americans, Hispanics/
Latinos, and transgender communities.
In part, to address these health
disparities, CDC first published
guidelines for HIV testing in health care
settings in 2003. CDC updated this
guidance to reflect changes in the
evidence base in 2006. As the
prevention landscape has evolved, so
too has CDC’s guidance for health care
providers. Most recently, CDC
published guidelines for health care
providers on pre-exposure prophylaxis
(PrEP) and recommendations for HIV
prevention with adults and adolescents
with HIV. Despite clear and compelling
guidance from CDC, past studies have
shown that patient-provider
communication about HIV testing and
prevention is uncommon and
conversations that do take place tend to
be brief.
CDC has developed four social
marketing campaigns to support patientprovider communication about HIV.
These campaigns have made great
strides in addressing health care
providers’ information needs, thereby

building their capacity to discuss HIV
prevention with their patients. At this
juncture, particularly with the evolving
HIV prevention landscape, more data
are needed to deepen our understanding
of providers’ interpretation and
understanding of existing and emergent
HIV prevention science; how providers
use guidance or evidence-based
approaches in their practices generally
as well with populations that have been
largely overlooked (e.g., transgender
individuals); and how to develop new
or enrich existing provider materials to
make them more informative, appealing,
and usable.
The three-year study proposes a series
of in-depth interviews with 600
healthcare providers (i.e., physicians,
physician assistants, and nurses)
identified by contractor staff and
professional recruiting firms. Data will
be collected through one-time, hourlong, individual, in-depth interviews
accompanied by a computer-assisted
personal interview (total of 1 hour and
15 minutes per person). We anticipate
screening 1,200 individuals to obtain
600 individuals who will participate in
a 1-hour, in-depth interview and
complete a 15-minute computer-assisted
personal interview (web-based) survey.
All data collections will be conducted
only one time. Respondents who will
participate in these interviews will be
selected purposively to inform the
development of appropriate messaging
and materials for healthcare providers.
Topic areas addressed within the
interviews may include HIV prevention,
HIV treatment, and linkage and referral
to services. Data will be securely stored
on password-protected computers and
in locked file cabinets.
The information gathered through this
data collection will allow CDC to
develop timely, relevant, clear, and
engaging materials that continue to
support patient-provider
communications related to HIV
prevention. Participation of respondents
is voluntary, and there is no cost to
respondents other than their time. The
total estimated annualized burden hours
are 950.

mstockstill on DSK4VPTVN1PROD with NOTICES

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of respondent

Form name

Health care providers ........................

Screener ..................................................
Web-based survey ...................................
Exploratory
guide—Prevention
with
positives and retention in care.
Exploratory guide—Transgender health ..

VerDate Sep<11>2014

17:46 Mar 18, 2016

Jkt 238001

PO 00000

Frm 00079

Fmt 4703

Sfmt 4703

Number of
responses
per
respondent

Average
burden per
response
(in hours)

Total burden
hours

1,200
600
50

1
1
1

10/60
15/60
1

200
150
50

50

1

1

50

E:\FR\FM\21MRN1.SGM

21MRN1

15113

Federal Register / Vol. 81, No. 54 / Monday, March 21, 2016 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent

Total ............................................

Total burden
hours

1
1
1
1

1
1
1
1

50
150
150
150

..................................................................

......................

......................

......................

950

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:

In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Health
Resources and Services Administration
(HRSA) has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period.
DATES: Comments on this ICR should be
received no later than April 20, 2016.
ADDRESSES: Submit your comments,
including the Information Collection
Request Title, to the desk officer for
HRSA, either by email to OIRA_
[email protected] or by fax to
202–395–5806.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email the
HRSA Information Collection Clearance
Officer at [email protected] or call
(301) 443–1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Maternal and Child Health Bureau
SUMMARY:

mstockstill on DSK4VPTVN1PROD with NOTICES

Average
burden per
response
(in hours)

50
150
150
150

[FR Doc. 2016–06248 Filed 3–18–16; 8:45 am]

17:46 Mar 18, 2016

Number of
responses
per
respondent

Exploratory guide—HIV prevention .........
Message testing guide ............................
Concept testing guide ..............................
Materials testing guide ............................

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.

VerDate Sep<11>2014

Number of
respondents

Form name

Jkt 238001

Performance Measures for Discretionary
Grants.
OMB No. 0915–0298—Revision.
Abstract: The Maternal and Child
Health Bureau’s (MCHB) Discretionary
Grant Information System (DGIS)
electronically captures performance
measure, program, financial, and
abstract data, and products and
publications about these discretionary
grants from the grantees. The data
collected are used by MCHB project
officers to monitor and assess grantee
performance as well as assist in
monitoring and evaluating MCHB’s
programs.
Need and Proposed Use of the
Information: The Health Resources and
Services Administration (HRSA)
proposes to continue using reporting
requirements for grant programs
administered by MCHB, including
national performance measures as
previously approved by OMB, and in
accordance with the ‘‘Government
Performance and Results Act (GPRA) of
1993’’ (Public Law 103–62). This Act
requires the establishment of
measurable goals for federal programs
that can be reported as part of the
budgetary process, thus linking funding
decisions with performance.
Performance measures for MCHB
discretionary grants were initially
approved in January 2003. Approval
from OMB is being sought to continue
the use of performance measures for
these grants. The revised performance
measures are categorized by population
domains (Adolescent Health, Child
Health, Children with Special Health
Care Needs, Lifecourse/Crosscutting,
Maternal/Women Health, and Perinatal/
Infant Health) consistent with Title V,
with the addition of a Capacity Building
domain, specific to DGIS. There are also
program-specific measures included for
a subset of discretionary grant programs
including the Healthy Start program,
Emergency Medical Services for
Children program, and programs within
the Division of MCH Workforce
Development. Grant programs will be
assigned measures in the domains that
are appropriate for their activities.

PO 00000

Frm 00080

Fmt 4703

Sfmt 4703

Comments were received related to
structure, content, and volume of
performance measures during the 60day public comment period and those
comments were taken into consideration
in the final revision of the DGIS
performance measures and overall DGIS
data collection.
MCHB’s purpose in revising the
performance measures is to better
measure progress toward program goals.
These program goals include alignment
with and support of the Title V Block
Grant, specifically population domains
and National Performance Measures,
where reasonable. Further, the revised
measures will more accurately capture
the scope of services provided through
this grant funding. The overall number
of performance measures has been
reduced from prior DGIS data
collection, and the average number of
performance measures each grantee will
be required to report is reduced as well.
Further, the structure of the data
collection has been revised to better
measure the various models of programs
and the services each funded program
provides. This revision will allow a
more accurate and detailed picture of
the full scope of services provided grant
programs administered by MCHB. The
data collected are also used by MCHB
project officers to monitor and assess
grantee performance as well as assist in
monitoring and evaluating MCHB’s
programs.
Likely Respondents: Discretionary
grant programs administered by the
Maternal and Child Health Bureau.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review

E:\FR\FM\21MRN1.SGM

21MRN1